The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: A reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction

FASEB Journal

Volumn 25, Issue 1, 2011, Pages 301-313

  Ding, Bo ^a   Gibbs, Peter E M ^a   Brookes, Paul S ^a   Maines, Mahin D ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Antioxidants; Apoptosis; Heart failure

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA ADRENERGIC RECEPTOR; BILIVERDIN; BILIVERDIN REDUCTASE; BROMETHOL; CYCLOHEXIMIDE; HEME OXYGENASE 2; HEPARIN; ISOPRENALINE; LYSYLLYSYLARGINYLISOLEUCYLLEUCYLHISTIDYLCYSTEINE; LYSYLTYROSYLCYSTEINYLCYSTEINYLSERYLARGINYLLYSINE; MESSENGER RNA; PEPTIDE DERIVATIVE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME STABILITY; EXPRESSION VECTOR; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE CONTRACTILITY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADRENERGIC BETA-AGONISTS; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART; HEK293 CELLS; HEME OXYGENASE (DECYCLIZING); HUMANS; ISOPROTERENOL; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 79251569558     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-166454     Document Type: Article

References (81)

1. Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., Reed, J. C., and Anversa, P. (1997) Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131-1141
2. Tomita, H., Nazmy, M., Kajimoto, K., Yehia, G., Molina, C. A., and Sadoshima, J. (2003) Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Circ. Res. 93, 12-22
3. Zaugg, M., Xu, W., Lucchinetti, E., Shafiq, S. A., Jamali, N. Z., and Siddiqui, M. A. (2000) Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102, 344-350
4. Bristow, M. R., Ginsburg, R., Umans, V., Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., Jamieson, S., and Stinson, E. B. (1986) Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ. Res. 59, 297-309
5. Del Monte, F., Kaumann, A. J., Poole-Wilson, P. A., Wynne, D. G., Pepper, J., and Harding, S. E. (1993) Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. Circulation 88, 854-863
6. Sethi, R., and Dhalla, N. S. (1995) Inotropic responses to isoproterenol in congestive heart failure subsequent to myocardial infarction in rats. J. Card. Fail. 1, 391-399
7. Grimm, D., Elsner, D., Schunkert, H., Pfeifer, M., Griese, D., Bruckschlegel, G., Muders, F., Riegger, G. A., and Kromer, E. P. (1998) Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc. Res. 37, 91-100 (Pubitemid 28122620)
8. Oudit, G. Y., Crackower, M. A., Eriksson, U., Sarao, R., Kozieradzki, I., Sasaki, T., Irie-Sasaki, J., Gidrewicz, D., Rybin, V. O., Wada, T., Steinberg, S. F., Backx, P. H., and Penninger, J. M. (2003) Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108, 2147-2152
9. Ferreira, A. J., Oliveira, T. L., Castro, M. C., Almeida, A. P., Castro, C. H., Caliari, M. V., Gava, E., Kitten, G. T., and Santos, R. A. (2007) Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-( 1-7) analogue AVE 0991. Life Sci. 81, 916-923
10. Choi, A. M. (2001) Heme oxygenase-1 protects the heart. Circ. Res. 89, 105-107
11. Masini, E., Vannacci, A., Marzocca, C., Pierpaoli, S., Giannini, L., Fantappie, O., Mazzanti, R., and Mannaioni, P. F. (2003) Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp. Biol. Med. (Maywood) 228, 546-549
12. Pachori, A. S., Melo, L. G., Hart, M. L., Noiseux, N., Zhang, L., Morello, F., Solomon, S. D., Stahl, G. L., Pratt, R. E., and Dzau, V. J. (2004) Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc. Natl. Acad. Sci. U. S. A. 101, 12282-12287 (Pubitemid 39145435)
13. Nakao, A., Neto, J. S., Kanno, S., Stolz, D. B., Kimizuka, K., Liu, F., Bach, F. H., Billiar, T. R., Choi, A. M., Otterbein, L. E., and Murase, N. (2005) Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am. J. Transplant. 5, 282-291
14. Giannini, L., Vannacci, A., Fabrizi, F., Uliva, C., Bani, D., Masini, E., and Mannaioni, P. F. (2005) Protection from cardiac injury by induction of heme oxygenase-1 and nitric oxide synthase in a focal ischaemia-reperfusion model. Cell. Mol. Biol. (Noisy-legrand) 51, 393-401
15. Yano, Y., Ozono, R., Oishi, Y., Kambe, M., Yoshizumi, M., Ishida, T., Omura, S., Oshima, T., and Igarashi, K. (2006) Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia/reperfusion in mice. Genes Cells 11, 791-803
16. Yamashita, K., Ollinger, R., McDaid, J., Sakahama, H., Wang, H., Tyagi, S., Csizmadia, E., Smith, N. R., Soares, M. P., and Bach, F. H. (2006) Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J. 20, 776-778
17. Immenschuh, S., and Schroder, H. (2006) Heme oxygenase-1 and cardiovascular disease. Histol. Histopathol. 21, 679-685
18. Ewing, J. F., and Maines, M. D. (1991) Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc. Natl. Acad. Sci. U. S. A. 88, 5364-5368
19. Florczyk, U. M., Jozkowicz, A., and Dulak, J. (2008) Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance. Pharmacol. Rep. 60, 38-48
20. Kapitulnik, J., and Maines, M. D. (2009) Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol. Sci. 30, 129-137
21. Ewing, J. F., Raju, V. S., and Maines, M. D. (1994) Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3′:5′-guanosine monophosphate. J. Pharmacol. Exp. Ther. 271, 408-414
22. Prabhakar, N. R., Dinerman, J. L., Agani, F. H., and Snyder, S. H. (1995) Carbon monoxide: a role in carotid body chemoreception. Proc. Natl. Acad. Sci. U. S. A. 92, 1994-1997
23. Ewing, J. F., and Maines, M. D. (1992) In situ hybridization and immunohistochemical localization of heme oxygenase-2 mRNA and protein in normal rat brain: Differential distribution of isozyme 1 and 2. Mol. Cell. Neurosci. 3, 559-570
24. Panahian, N., and Maines, M. D. (2001) Site of injury-directed induction of heme oxygenase-1 and -2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms? J. Neurochem. 76, 539-554
25. Miller, S. M., Farrugia, G., Schmalz, P. F., Ermilov, L. G., Maines, M. D., and Szurszewski, J. H. (1998) Heme oxygenase 2 is present in interstitial cell networks of the mouse small intestine. Gastroenterology 114, 239-244
26. Kim, Y. S., Zhuang, H., Koehler, R. C., and Dore, S. (2005) Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. Free Radic. Biol. Med. 38, 85-92 (Pubitemid 39626912)
27. Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., and Snyder, S. H. (1993) Carbon monoxide: a putative neural messenger. Science 259, 381-384
28. Prabhakar, N. R. (1999) NO and CO as second messengers in oxygen sensing in the carotid body. Respir. Physiol. 115, 161-168
29. Ryter, S. W., Morse, D., and Choi, A. M. (2007) Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am. J. Respir. Cell. Mol. Biol. 36, 175-182
30. Maghzal, G. J., Leck, M. C., Collinson, E., Li, C., and Stocker, R. (2009) Limited role for the bilirubin-biliverdin redox amplifi- cation cycle in the cellular antioxidant protection by biliverdin reductase. J. Biol. Chem. 284, 29251-29259
31. Miralem, T., Hu, Z., Torno, M. D., Lelli, K. M., and Maines, M. D. (2005) Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J. Biol. Chem. 280, 17084-17092
32. Baranano, D. E., Rao, M., Ferris, C. D., and Snyder, S. H. (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. U. S. A. 99, 16093-16098
33. Sedlak, T. W., Saleh, M., Higginson, D. S., Paul, B. D., Juluri, K. R., and Snyder, S. H. (2009) Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc. Natl. Acad. Sci. U. S. A. 106, 5171-5176
34. Rotenberg, M. O., and Maines, M. D. (1990) Isolation, characterization, and expression in Escherichia coli of a cDNA encoding rat heme oxygenase-2. J. Biol. Chem. 265, 7501-7506
35. Rublevskaya, I., and Maines, M. D. (1994) Interaction of Feprotoporphyrin IX and heme analogues with purified recombinant heme oxygenase-2, the constitutive isozyme of the brain and testes. J. Biol. Chem. 269, 26390-26395
36. McCoubrey, W. K., Jr., Huang, T. J., and Maines, M. D. (1997) Heme oxygenase-2 is a hemoprotein and binds heme through heme regulatory motifs that are not involved in heme catalysis. J. Biol. Chem. 272, 12568-12574
37. Yi, L., Jenkins, P. M., Leichert, L. I., Jakob, U., Martens, J. R., and Ragsdale, S. W. (2009) Heme regulatory motifs in heme oxygenase-2 form a thiol/disulfide redox switch that responds to the cellular redox state. J. Biol. Chem. 284, 20556-20561
38. Maines, M. D. (1997) The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554
39. Williams, S. E., Wootton, P., Mason, H. S., Bould, J., Iles, D. E., Riccardi, D., Peers, C., and Kemp, P. J. (2004) Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306, 2093-2097
40. + channel-dependent chemotransduction. Biochem. Biophys. Res. Commun. 338, 648-652
41. Lerner-Marmarosh, N., Shen, J., Torno, M. D., Kravets, A., Hu, Z., and Maines, M. D. (2005) Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc. Natl. Acad. Sci. U. S. A. 102, 7109-7114
42. Maines, M. D. (2007) Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways. Antioxid. Redox Signal. 9, 2187-2195
43. Lerner-Marmarosh, N., Miralem, T., Gibbs, P. E., and Maines, M. D. (2007) Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase. FASEB J. 21, 3949-3962
44. Carnegie, G. K., Means, C. K., and Scott, J. D. (2009) A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 61, 394-406
45. McKnight, G. S., Cummings, D. E., Amieux, P. S., Sikorski, M. A., Brandon, E. P., Planas, J. V., Motamed, K., and Idzerda, R. L. (1998) Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Prog. Horm. Res. 53, 139-159; discussion 160-131
46. Kravets, A., Hu, Z., Miralem, T., Torno, M. D., and Maines, M. D. (2004) Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1. J. Biol. Chem. 279, 19916-19923
47. Ding, B., Abe, J., Wei, H., Huang, Q., Walsh, R. A., Molina, C. A., Zhao, A., Sadoshima, J., Blaxall, B. C., Berk, B. C., and Yan, C. (2005) Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure. Circulation 111, 2469-2476
48. Ding, B., Abe, J., Wei, H., Xu, H., Che, W., Aizawa, T., Liu, W., Molina, C. A., Sadoshima, J., Blaxall, B. C., Berk, B. C., and Yan, C. (2005) A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc. Natl. Acad. Sci. U. S. A. 102, 14771-14776
49. Maines, M. D., Miralem, T., Lerner-Marmarosh, N., Shen, J., and Gibbs, P. E. (2007) Human biliverdin reductase, a previously unknown activator of protein kinase C betaII. J. Biol. Chem. 282, 8110-8122
50. Huang, T. J., Trakshel, G. M., and Maines, M. D. (1989) Detection of 10 variants of biliverdin reductase in rat liver by two-dimensional gel electrophoresis. J. Biol. Chem. 264, 7844-7849
51. Tudor, C., Lerner-Marmarosh, N., Engelborghs, Y., Gibbs, P. E., and Maines, M. D. (2008) Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin. Biochem. J. 413, 405-416
52. Tompkins, A. J., Burwell, L. S., Digerness, S. B., Zaragoza, C., Holman, W. L., and Brookes, P. S. (2006) Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim. Biophys. Acta 1762, 223-231 (Pubitemid 43006028)
53. Hayes, J. S., Wyss, V. L., Schenck, K. S., and Cohen, M. L. (1986) Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists. J. Pharmacol. Exp. Ther. 237, 757-763
54. Hu, A., Jiao, X., Gao, E., Koch, W. J., Sharifi-Azad, S., Grunwald, Z., Ma, X. L., and Sun, J. Z. (2006) Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress. J. Pharmacol. Exp. Ther. 318, 469-475
55. Lerner-Marmarosh, N., Miralem, T., Gibbs, P. E., and Maines, M. D. (2008) Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc. Natl. Acad. Sci. U. S. A. 105, 6870-6875
56. Steinberg, S. F. (1999) The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ. Res. 85, 1101-1111
57. Nikolaev, V. O., Moshkov, A., Lyon, A. R., Miragoli, M., Novak, P., Paur, H., Lohse, M. J., Korchev, Y. E., Harding, S. E., and Gorelik, J. (2010) Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327, 1653-1657
58. Raju, V. S., McCoubrey, W. K., Jr., and Maines, M. D. (1997) Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim. Biophys. Acta 1351, 89-104
59. Walker, B. R. (2007) Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 157, 545-559
60. Slebos, D. J., Ryter, S. W., and Choi, A. M. (2003) Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir. Res. 4, 7
61. Li Volti, G., Rodella, L. F., Di Giacomo, C., Rezzani, R., Bianchi, R., Borsani, E., Gazzolo, D., and Motterlini, R. (2006) Role of carbon monoxide and biliverdin in renal ischemia/reperfusion injury. Nephron Exp. Nephrol. 104, e135-139
62. Li Volti, G., Sorrenti, V., Murabito, P., Galvano, F., Veroux, M., Gullo, A., Acquaviva, R., Stacchiotti, A., Bonomini, F., Vanella, L., and Di Giacomo, C. (2007) Pharmacological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury. Transplant. Proc. 39, 2986-2991
63. Bolognesi, M., Sacerdoti, D., Piva, A., Di Pascoli, M., Zampieri, F., Quarta, S., Motterlini, R., Angeli, P., Merkel, C., and Gatta, A. (2007) Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J. Pharmacol. Exp. Ther. 321, 187-194
64. Chung, H. T., Choi, B. M., Kwon, Y. G., and Kim, Y. M. (2008) Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation. Methods Enzymol. 441, 329-338
65. Ryter, S. W., and Choi, A. M. (2009) Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am. J. Respir. Cell Mol. Biol. 41, 251-260
66. Gozzelino, R., Jeney, V., and Soares, M. P. (2010) Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50, 323-354
67. Abuarqoub, H., Green, C. J., Foresti, R., and Motterlini, R. (2007) Curcumin reduces cold storage-induced damage in human cardiac myoblasts. Exp. Mol. Med. 39, 139-148
68. Ding, Y., McCoubrey, W. K., Jr., and Maines, M. D. (1999) Interaction of heme oxygenase-2 with nitric oxide donors. Is the oxygenase an intracellular 'sink' for NO? Eur. J. Biochem. 264, 854-861
69. Xu, W., Liu, L., Charles, I. G., and Moncada, S. (2004) Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response. Nat. Cell Biol. 6, 1129-1134
70. Erusalimsky, J. D., and Moncada, S. (2007) Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler. Thromb. Vasc. Biol. 27, 2524-2531
71. Kinobe, R. T., Dercho, R. A., and Nakatsu, K. (2008) Inhibitors of the heme oxygenase-carbon monoxide system: on the doorstep of the clinic? Can. J. Physiol. Pharmacol. 86, 577-599
72. Hu, C. M., Chen, Y. H., Chiang, M. T., and Chau, L. Y. (2004) Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 110, 309-316
73. Brunt, K. R., Tsuji, M. R., Lai, J. H., Kinobe, R. T., Durante, W., Claycomb, W. C., Ward, C. A., and Melo, L. G. (2009) Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes. Exp. Biol. Med. (Maywood) 234, 582-594
74. Jadhav, A., Torlakovic, E., and Ndisang, J. F. (2008) Interaction among heme oxygenase, nuclear factor-κB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension 52, 910-917
75. Yeh, C. H., Chen, T. P., Wang, Y. C., Lin, Y. M., and Lin, P. J. (2009) HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-κB and AP-1 translocation following cardiac global ischemia and reperfusion. J. Surg. Res. 155, 147-156
76. Das, D. K., and Maulik, N. (2006) Cardiac genomic response following preconditioning stimulus. Cardiovasc. Res. 70, 254-263
77. van Empel, V. P., and De Windt, L. J. (2004) Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc. Res. 63, 487-499
78. Whelan, R. S., Kaplinskiy, V., and Kitsis, R. N. (2010) Cell death in the pathogenesis of heart disease: mechanisms and signifi- cance. Annu. Rev. Physiol. 72, 19-44
79. Marshall, D., and Sack, M. N. (2000) Apoptosis: a pivotal event or an epiphenomenon in the pathophysiology of heart failure? Heart 84, 355-356
80. Pachori, A. S., Smith, A., McDonald, P., Zhang, L., Dzau, V. J., and Melo, L. G. (2007) Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J. Mol. Cell. Cardiol. 43, 580-592
81. Wegiel, B., Baty, C. J., Gallo, D., Csizmadia, E., Scott, J. R., Akhavan, A., Chin, B. Y., Kaczmarek, E., Alam, J., Bach, F. H., Zuckerbraun, B. S., and Otterbein, L. E. (2009) Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 284, 21369-21378